Hasan İkbal ATILGAN, Meliha KORKMAZ, Murat SADIÇ

LOKAL VE DİFFÜZ TC-99M KEMİK AJANLARININ KALPTE TUTULUMLARI- LİTERATÜR TARAMA VE GAMUT

LOCAL AND DIFFUSE UPTAKE OF TECHNETIUM-99M BONE TRACERS IN THE MYOCARDIUM-LITERATURE REVIEW AND GAMUT

PDF

___

1)Demirel K, Sadic M, Korkmaz M, Comak A, Atilgan HI, Koca G. Diffuse Myocardial Uptake of 99mTc-HDP in Multiple Myeloma. Nuclear Medicine and Molecular Imaging. 2013; 47: 208-11.
2)Challa S, Miller JH. Extraskeletal uptake of technetium-99m-MDP in sites of heparin administration. J Nucl Med. 1998; 39: 893-5.
3)Pickhardt PJ, McDermott M. Intense uptake of technetium-99m-MDP in primary breast adenocarcinoma with sarcomatoid metaplasia. J Nucl Med. 1997; 38: 528-30.
4)Tuncel M, Erbas B, Mahmoudian B. Gamut: soft tissue uptake of bone radiopharmaceuticals. Semin Nucl Med. 2003 Oct; 33(4): 334-7.
5)Eguchi M, Tsuchihashi K, Takizawa H, et al. Detection of cardiac calcinosis in hemodialysis patients by whole-body scintigraphy with 99m-technetium methylene diphosphonate. Am J Nephrol. 2000; 20: 278-82.
6)Braga FJ, Miranda JR, Lucca LJ, Garcia TM, Ferraz AS. Heart and lung accumulation of Tc-99m MDP with normal radiographs in patients undergoing hemodialysis. Clin Nucl Med. 2000; 25: 377-8.
7)Sahin A, Seven B, Yildirim M, Varoglu E. Heart and soft-tissue uptake of Tc-99m MDP in a hemodialysis patient. Clin Nucl Med. 2004; 29: 854-5.
8)Soni S, Leslie WD. Bone scan findings in metastatic calcification from calciphylaxis. Clin Nucl Med. 2008; 33: 502-4.
9)Seid K, Lin D, Flowers WM Jr. Intense myocardial uptake of Tc-99m-MDP in a case of hypercalcemia. Clin Nucl Med. 1981; 6: 565-7.
10)Atkins HL, Oster ZH. Myocardial uptake of a bone tracer associated with hypercalcemia. Clin Nucl Med. 1984; 9: 613-5.
11)Kida T, Hujita Y, Sasaki M, Inoue J. Myocardial and vascular uptake of a bone tracer associated with secondary hyperparathyroidism. Eur J Nucl Med. 1986; 12: 151-4.
12)Janowitz WR, Serafini AD. Intense myocardial uptake of 99mTc-diphosphonate in a uremic patient with secondary hyperparathyroidism and pericarditis: case report. J Nucl Med. 1976; 17: 896-8.
13)Wald RW, Sternberg L, Huckell VF, et al. Technetium-99m stannous pyrophosphate scintigraphy in patients with calcification within the cardiac silhouette. Br Heart J. 1978; 40: 547-51.
14)Burns N, Shriki JE, Farvid AM, et al. Calcific constrictive pericarditis demonstrated on 99mTc-MDP bone scintigraphy. J Radiol Case Rep. 2009; 3: 11-5.
15)Valdez VA, Jacobstein JG. Visualization of a malignant pericardial effusion with Tc-99m-EHDP. Clin Nucl Med. 1980; 5: 210-2.
16)Ahmad M, Dubiel JP. Tc-99m pyrophosphate myocardial imaging in perimyocarditis. J Nucl Med. 1981; 22: 452-4.
17)Kawase T, Fujii H, Nakahara T, Shigematsu N, Kubo A, Kosuda S. Intense accumulation of Tc-99m MDP in pericardial metastasis from breast cancer. Clin Nucl Med. 2009; 34: 173-4.
18)Wells RG, Ruskin JA, Sty JR. Myocardial imaging. Coxsackie myocarditis. Clin Nucl Med. 1986; 11: 661-2.
19)Holman BL, Chisholm RJ, Braunwald E. The prognostic implications of acute myocardial infarct scintigraphy with 99mTc-pyrophosphate. Circulation. 1978; 57: 320-6.
20)Perez LA, Hayt DB, Freeman LM. Localization of myocardial disorders other than infarction with 99mTc-labeled phosphate agents. J Nucl Med. 1976; 17: 241-6.
21)Chacko AK, Gordon DH, Bennett JM, O'Mara RE, Wilson GA. Myocardial imaging with Tc-99m pyrophosphate in patients on adriamycin treatment for neoplasia. J Nucl Med. 1977; 18: 680-3.
22)Landgarten S, Gordon R. Radionuclide demonstrations of adriamycin-induced cardiac toxicity. Clin Nucl Med. 1977; 2: 429-30.
23)Soin JS, Cox JD, Youker JE, Swartz HM. Cardiac localization of 99mTc-(Sn)-pyrophosphate following irradiation of the chest. Radiology. 1977; 124: 165-8.
24)Poblete García VM, Rodado Marina S, García Vicente A, Soriano Castrejón A. Benign myocardial uptake of 99mTc-HMDP in prostate carcinoma: based on three cases. Rev Esp Med Nucl. 2003; 22: 35-9.
25)Chadrawar S, George M, Al-Akraa M, Herber M, Buscombe J. Myocardial uptake of Tc-99m HDP in a patient with prostate carcinoma. Nucl Med Rev Cent East Eur. 2009; 12: 78-80.
26)Jones A, Keeling D. Benign myocardial uptake of hydroxymethylene diphosphonate. Nucl Med Commun. 1994; 15: 21-3.
27)Gupta AK, Meyer P, Gross MD, Fig LM, Shapiro B. Altered radiopharmaceutical distribution in myeloma: bone tracer in the heart and heart tracer in the bone. Clin Nucl Med. 1998; 23: 820–3.
28)Kanoh T, Uchino H, Yamamoto I, Torizuka K. Soft-tissue uptake of technetium-99m MDP in multiple myeloma. Clin Nucl Med. 1986; 11: 878-9.
29)Hongo M, Yamada H, Okubo S, et al. Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation. J Cardiogr. 1985; 15: 163-80.
30)Wadhwa SS, Nour R. Tc-99m HDP uptake in cardiac amyloidosis. Clin Nucl Med. 1999; 24: 156-8.
31)Kulhanek J, Movahed A. Uptake of technetium 99m HDP in cardiac amyloidosis. Int J Cardiovasc Imaging. 2003; 19: 225-7.
32)Ak I, Vardareli E, Erdinĉ O, Kasapoğlu E, Ata N. Myocardial Tc-99m MDP uptake on a bone scan in senile systemic amyloidosis with cardiac involvement. Clin Nucl Med. 2000; 25: 826-7.
33)Nakata T, Shimamoto K. Cardiac denervation in amyloid polyneuropathy. Lancet. 2003; 361: 1181.
34)Singh A, Usher M. Comparison of Tc-99m methylene diphosphonate with Tc-99m pyrophosphate in the detection of acute myocardial infarction: concise communication. J Nucl Med 1977; 18: 790-2.
35)Huckell VF, Lyster DM, Morrison RT, Cooper JA. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction. Clin Nucl Med. 1985; 10: 455-62.
36)Malin FR, Rollo FD, Gertz EW. Sequential myocardial scintigraphy with technetium-99m stannous pyrophosphate following myocardial infarction. J Nucl Med. 1978; 19: 1111-5.
37)Olson HG, Lyons KP, Aronow WS, et al. Prognostic value of a persistently positive technetium-99m stannous pyrophosphate myocardial scintigram after myocardial infarction. Am J Cardiol. 1979; 43: 889-98.
38)Jaffe AS, Klein MS, Patel BR, Siegel BA, Roberts R. Abnormal technetium-99m pyrophosphate images in unstable angina: ischemia versus infarction? Am J Cardiol. 1979; 44: 1035-9.
39)Miller DG, Gilmour RF, Grossman ZD, et al. Myocardial uptake of Tc-99m skeletal agents in the rat after experimental induction of microscopic foci of injury. J Nucl Med. 1977; 18: 1005-9.
40)Ahmad M, Dubiel JP, Verdon TA, Martin RH. Technetium 99m stannous pyrophosphate myocardial imaging in patients with and without left ventricular aneurysm. Circulation. 1976; 53: 833-8.
41)Kerber G, Ryan JW, Karunaratne HB. Enterococcal endocarditis: a rare cause of focal cardiac uptake in infarct-avid myocardial scintigraphy. Arch Intern Med. 1982; 142: 1360-2.
42)Harford W, Weinberg MN, Buja LM, et al. Positive 99mTc-stannous pyrophosphate myocardial image in a patient with carcinoma of the lung. Radiology. 1977; 122: 747-8.
43)Singh A, Usher M, Raphael L. Pericardial accumulation of Tc-99m methylene diphosphonate in a case of pericarditis. J Nucl Med. 1977; 18: 1141-2.
44)Jengo JA, Mena I, Joe SH, Criley JM. The significance of calcific valvular heart disease in Tc-99m pyrophosphate myocardial infarction scanning: radiographic, scintigraphic, and pathological correlation. J Nucl Med. 1977; 18: 776-80.
45)Righetti A, O'Rourke RA, Schelbert H, et al. Usefulness of preoperative and postoperative Tc-99m (Sn)-pyrophosphate scans in patients with ischemic and valvular heart disease. Am J Cardiol. 1977; 39: 43-9.
46)Breitz HB, Sirotta PS, Graham MM. Cardiac calcification causing arrhythmia detected by technetium-99m MDP and SPECT. Clin Nucl Med. 1988;13:153-4.
47)Datz FL, Lewis SE, Parkey RW, et al. Radionuclide evaluation of cardiac trauma. Semin Nucl Med. 1980; 10: 187-92.
48)Banzo I, Montero A, Uriarte I, et al. Coronary artery occlusion and myocardial infarction: a seldom encountered complication of blunt chest trauma. Clin Nucl Med. 1999; 24: 94-6.
49)Davison R, Spies SM, Przybylek J, Hai H, Lesch M. Technetium-99m stannous pyrophosphate myocardial scintigraphy after cardiopulmonary resuscitation with cardioversion. Circulation. 1979; 60: 292-6.
50)Palestro CJ, Steele MK, Kim CK, Goldsmith SJ. Myocardial uptake of Tc-99m MDP following cardioversion. Clin Nucl Med. 1991; 16: 273-4.
51)Kao PF, Tzen KY, Chang LY, You DL, Yang JY. 99mTc-MDP scintigraphy in high-voltage electrical burn patients. Nucl Med Commun. 1997; 18: 846-52.
52)Macdonald WB, Troedson RG. Unexpected myocardial uptake on bone scintigraphy in an infant with Kawasaki disease. Clin Nucl Med. 2001; 26: 455.
53)da Rocha AF, Meguerian BA, Harbert JC. Tc-99m pyrophosphate myocardial scanning in Chagas' disease. J Nucl Med. 1981; 22: 347-8.